Patients affect by Lynch syndrome are characterized by mutations in the genes of the mismatch repair GO group (MLH1, MSH2, MSH6, PMS2, EPCAM), determining increased risk of cancer, and this risk is higher in presence of elevated cholesterol levels [14]. Here, MLH1 is linked to Lynch syndrome.